SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-069141
Filing Date
2023-08-21
Accepted
2023-08-21 08:21:30
Documents
57
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_adialpharma.htm   iXBRL 10-Q 601142
2 CERTIFICATION f10q0623ex31-1_adial.htm EX-31.1 11004
3 CERTIFICATION f10q0623ex31-2_adial.htm EX-31.2 11058
4 CERTIFICATION f10q0623ex32-1_adial.htm EX-32.1 4398
5 CERTIFICATION f10q0623ex32-2_adial.htm EX-32.2 4316
  Complete submission text file 0001213900-23-069141.txt   4088359

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adil-20230630.xsd EX-101.SCH 50609
7 XBRL CALCULATION FILE adil-20230630_cal.xml EX-101.CAL 34852
8 XBRL DEFINITION FILE adil-20230630_def.xml EX-101.DEF 215178
9 XBRL LABEL FILE adil-20230630_lab.xml EX-101.LAB 444816
10 XBRL PRESENTATION FILE adil-20230630_pre.xml EX-101.PRE 228646
51 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_adialpharma_htm.xml XML 409579
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 231187392
SIC: 2834 Pharmaceutical Preparations